This document is an excerpt from the EUR-Lex website
Document 52006XC0908(03)
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.7.2006 to 31.7.2006 (Decisions taken pursuant to Article 34 of Directive 2001/83/ECor Article 38 of Directive 2001/82/EC)
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.7.2006 to 31.7.2006 (Decisions taken pursuant to Article 34 of Directive 2001/83/ECor Article 38 of Directive 2001/82/EC)
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.7.2006 to 31.7.2006 (Decisions taken pursuant to Article 34 of Directive 2001/83/ECor Article 38 of Directive 2001/82/EC)
SL C 217, 8.9.2006, p. 13–35
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
8.9.2006 |
EN |
Official Journal of the European Union |
C 217/13 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.7.2006 to 31.7.2006
(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1)or Article 38 of Directive 2001/82/EC (2))
(2006/C 217/04)
— Issuing, maintenance or modification of a national marketing authorisation
Date of the decision |
Name(s) of the medicinal product |
Holder(s) of the marketing authorization |
Member State concerned |
Date of notification |
4.7.2006 |
STAMARIL |
See Annex I |
See Annex I |
6.7.2006 |
4.7.2006 |
Viani Evohaler |
See Annex II |
See Annex II |
5.7.2006 |
4.7.2006 |
Seretide Diskus |
See Annex III |
See Annex III |
5.7.2006 |
4.7.2006 |
Viani Diskus |
See Annex IV |
See Annex IV |
5.7.2006 |
4.7.2006 |
Seretide Evohaler |
See Annex V |
See Annex V |
5.7.2006 |
(1) OJ L 311, 28.11.2001, p. 67.
(2) OJ L 311, 28.11.2001, p. 1.
ANNEX I
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State |
Marketing Authorisation Holder |
Name |
Strength |
Pharmaceutical Form |
Route of administration |
|||||||
Austria |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Belgium |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Czech Republic |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Denmark |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Estonia |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Finland |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
France |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Germany |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Hungary |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Ireland |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Italy |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Latvia |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Lithuania |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Luxemburg |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Poland |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Portugal |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Slovakia |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Spain |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Sweden |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
The Netherlands |
|
STAMARIL Pasteur |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
United Kingdom |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Iceland |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
|||||||
Norway |
|
STAMARIL |
Not less than 1 000 LD50 units |
Powder and solvent for suspension for injection |
Subcutaneous use (preferred) or intramuscular use |
ANNEX II
LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State |
Marketing Authorisation Holder |
Product Name |
Strength |
Pharmaceutical Form |
Route of administration |
|||||
Austria |
|
Viani forte Dosieraerosol |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Austria |
|
Viani standard Dosieraerosol |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Austria |
|
Viani junior Dosieraerosol |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Belgium |
|
Viani 25/125 |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Belgium |
|
Viani 25/250 |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Belgium |
|
Viani 25/50 |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Finland |
|
Viani Evohaler |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Finland |
|
Viani Evohaler |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Finland |
|
Viani Evohaler |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
France |
|
Viani |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
France |
|
Viani |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
France |
|
Viani |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Germany |
|
Viani mite Dosier-Aerosol FCKW-frei 25 mg/50 mg Druckgasinhalation, Suspension |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Germany |
|
Viani Dosier-Aerosol FCKW-frei 25 mg/125 mg Druckgasinhalation, Suspension |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Germany |
|
Viani forte Dosier-Aerosol FCKW-frei 25 mg/250 mg Druckgasinhalation, Suspension |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Ireland |
|
Viani Evohaler |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Ireland |
|
Viani Evohaler |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Ireland |
|
Viani Evohaler |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Italy |
|
Aliflus |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Italy |
|
Aliflus |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Italy |
|
Aliflus |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Luxembourg |
|
Viani 25/50 |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Luxembourg |
|
Viani 25/125 |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Luxembourg |
|
Viani 25/250 |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Portugal |
|
Veraspir Inalador |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Portugal |
|
Veraspir Inalador |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Portugal |
|
Veraspir Inalador |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Spain |
|
Brisair 25/125 |
25/125 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Spain |
|
Brisair 25/250 |
25/250 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Spain |
|
Brisair 25/50 |
25/50 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Sweden |
|
Viani Evohaler mite |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Sweden |
|
Viani Evohaler |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Sweden |
|
Viani Evohaler forte |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
United Kingdom |
|
Viani 50 Evohaler |
25/50 |
Pressurised inhalation suspension |
Inhalation use |
|||||
United Kingdom |
|
Viani 125 Evohaler |
25/125 |
Pressurised inhalation suspension |
Inhalation use |
|||||
United Kingdom |
|
Viani 250 Evohaler |
50/250 |
Pressurised inhalation suspension |
Inhalation use |
ANNEX III
LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State |
Marketing Authorisation Holder |
Product Name |
Strength |
Pharmaceutical Form |
Route of administration |
|||||
Austria |
|
Seretide Diskus forte |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Austria |
|
Seretide Diskus standard |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Austria |
|
Seretide Diskus junior |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Belgium |
|
Seretide 50/100 Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Belgium |
|
Seretide 50/250 Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Belgium |
|
Seretide 50/500 Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Denmark |
|
Seretide |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Denmark |
|
Seretide |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Denmark |
|
Seretide |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Finland |
|
Seretide Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Finland |
|
Seretide Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Finland |
|
Seretide Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
France |
|
Seretide Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
France |
|
Seretide Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
France |
|
Seretide Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Germany |
|
atmadisc mite 50mg/100mg Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Germany |
|
atmadisc 50mg/250mg Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Germany |
|
atmadisc forte 50mg/500mg Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Greece |
|
Seretide Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Greece |
|
Seretide Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Greece |
|
Seretide Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Ireland |
|
Seretide Diskus 100 |
50/100 |
Inhalation powder, predispensed. |
Inhalation use |
|||||
Ireland |
|
Seretide Diskus 250 |
50/250 |
Inhalation powder, predispensed. |
Inhalation use |
|||||
Ireland |
|
Seretide Diskus 500 |
50/500 |
Inhalation powder, predispensed. |
Inhalation use |
|||||
Italy |
|
Seretide Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Italy |
|
Seretide Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Italy |
|
Seretide Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Luxembourg |
|
Seretide 50/100 Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Luxembourg |
|
Seretide 50/250 Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Luxembourg |
|
Seretide 50/500 Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Portugal |
|
Seretaide Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Portugal |
|
Seretaide Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Portugal |
|
Seretaide Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Spain |
|
Seretide Accuhaler |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Spain |
|
Seretide Accuhaler |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Spain |
|
Seretide Accuhaler |
50/500 |
inhalation powder, predispensed |
Inhalation use |
|||||
Sweden |
|
Seretide Diskus mite |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Sweden |
|
Seretide Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Sweden |
|
Seretide Diskus forte |
50/500 |
inhalation powder, predispensed |
Inhalation use |
|||||
The Netherlands |
|
Seretide 50/100 Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
The Netherlands |
|
Seretide 50/250 Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
The Netherlands |
|
Seretide 50/500 Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
United Kingdom |
|
Seretide 100 Accuhaler |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
United Kingdom |
|
Seretide 250 Accuhaler |
50/250 |
Inhalation powder, predispensed |
Iinhalation use |
|||||
United Kingdom |
|
Seretide 500 Accuhaler |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
ANNEX IV
LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State |
Marketing Authorisation Holder |
Product Name |
Strength |
Pharmaceutical Form |
Route of administration |
|||||
Austria |
|
Viani Diskus forte |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Austria |
|
Viani Diskus standard |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Austria |
|
Viani Diskus junior |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Belgium |
|
Viani 50/100 Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Belgium |
|
Viani 50/250 Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Belgium |
|
Viani 50/500 Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Finland |
|
Viani Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Finland |
|
Viani Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Finland |
|
Viani Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
France |
|
Viani Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
France |
|
Viani Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
France |
|
Viani Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Germany |
|
Viani mite 50 mg/100 mg Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Germany |
|
Viani 50 mg/250 mg Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Germany |
|
Viani forte 50 mg/500 mg Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Ireland |
|
Viani Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Ireland |
|
Viani Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Ireland |
|
Viani Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Italy |
|
Aliflus Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Italy |
|
Aliflus Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Italy |
|
Aliflus Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Luxembourg |
|
Viani 50/100 Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Luxembourg |
|
Viani 50/250 Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Luxembourg |
|
Viani 50/500 Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Portugal |
|
Veraspir Diskus |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Portugal |
|
Veraspir Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Portugal |
|
Veraspir Diskus |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Spain |
|
Brisair Accuhaler |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Spain |
|
Brisair Accuhaler |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Spain |
|
Brisair Accuhaler 50 |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Sweden |
|
Viani Diskus mite |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Sweden |
|
Viani Diskus |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
Sweden |
|
Viani Diskus forte |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
|||||
United Kingdom |
|
Viani 100 Accuhaler |
50/100 |
Inhalation powder, predispensed |
Inhalation use |
|||||
United Kingdom |
|
Viani 250 Accuhaler |
50/250 |
Inhalation powder, predispensed |
Inhalation use |
|||||
United Kingdom |
|
Viani 500 Accuhaler |
50/500 |
Inhalation powder, predispensed |
Inhalation use |
ANNEX V
LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State |
Marketing Authorisation Holder |
Product Name |
Strength |
Pharmaceutical Form |
Route of administration |
|||||
Austria |
|
Seretide forte Dosieraerosol |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Austria |
|
Seretide standard Dosieraerosol |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Austria |
|
Seretide junior Dosieraerosol |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Belgium |
|
Seretide 25/125 |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Belgium |
|
Seretide 25/250 |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Belgium |
|
Seretide 25/50 |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Denmark |
|
Seretide |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Denmark |
|
Seretide |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Denmark |
|
Seretide |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Finland |
|
Seretide Evohaler |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Finland |
|
Seretide Evohaler |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Finland |
FIN-02231 Espoo |
Seretide Evohaler |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
France |
|
Seretide |
25/50 |
Pressurised inhalation suspension |
Inhalation use |
|||||
France |
|
Seretide |
25/125 |
Pressurised inhalation suspension |
Inhalation use |
|||||
France |
|
Seretide |
25/250 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Germany |
|
atmadisc mite Dosier-Aerosol FCKW-frei 25 mg/50 mg Druckgasinhalation, Suspension |
25/50 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Germany |
|
atmadisc Dosier-Aerosol FCKW-frei 25 mg/125 mg Druckgasinhalation, Suspension |
25/125 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Germany |
|
atmadisc forte Dosier-Aerosol FCKW-frei 25 mg/250 mg Druckgasinhalation, Suspension |
25/250 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Greece |
|
Seretide Inhaler |
25/250 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Greece |
|
Seretide Inhaler |
25/50 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Greece |
|
Seretide Inhaler |
25/125 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Iceland |
|
Seretide |
25/50 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Iceland |
|
Seretide |
25/125 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Iceland |
|
Seretide |
25/250 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Ireland |
|
Seretide 50 Evohaler |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Ireland |
|
Seretide 125 Evohaler |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Ireland |
|
Seretide 250 Evohaler |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Italy |
|
Seretide |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Italy |
|
Seretide |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Italy |
|
Seretide |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Luxembourg |
|
Seretide 25/50 |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Luxembourg |
|
Seretide 25/125 |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Luxembourg |
|
Seretide 25/250 |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Portugal |
|
Seretaide Inalador |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Portugal |
|
Seretaide Inalador |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Portugal |
|
Seretaide Inalador |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Spain |
|
Seretide 25/50 |
25/50 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Spain |
|
Seretide 25/125 |
25/125 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Spain |
|
Seretide 25/250 |
25/250 |
Pressurised inhalation suspension |
Inhalation use |
|||||
Sweden |
|
Seretide Evohaler mite |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Sweden |
|
Seretide Evohaler |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
Sweden |
|
Seretide Evohaler forte |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
The Netherlands |
|
Seretide 25/50 |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
The Netherlands |
|
Seretide 25/125 |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
The Netherlands |
|
Seretide 25/250 |
25/250 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
United Kingdom |
|
Seretide 50 Evohaler |
25/50 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
United Kingdom |
|
Seretide 125 Evohaler |
25/125 |
Pressurised inhalation, suspension |
Inhalation use |
|||||
United Kingdom |
|
Seretide 250 Evohaler |
50/250 |
Pressurised inhalation, suspension |
Inhalation use |